» Articles » PMID: 38203940

Hydrogels in Ophthalmology: Novel Strategies for Overcoming Therapeutic Challenges

Overview
Publisher MDPI
Date 2024 Jan 11
PMID 38203940
Authors
Affiliations
Soon will be listed here.
Abstract

The human eye's intricate anatomical and physiological design necessitates tailored approaches for managing ocular diseases. Recent advancements in ophthalmology underscore the potential of hydrogels as a versatile therapeutic tool, owing to their biocompatibility, adaptability, and customizability. This review offers an exploration of hydrogel applications in ophthalmology over the past five years. Emphasis is placed on their role in optimized drug delivery for the posterior segment and advancements in intraocular lens technology. Hydrogels demonstrate the capacity for targeted, controlled, and sustained drug release in the posterior segment of the eye, potentially minimizing invasive interventions and enhancing patient outcomes. Furthermore, in intraocular lens domains, hydrogels showcase potential in post-operative drug delivery, disease sensing, and improved biocompatibility. However, while their promise is immense, most hydrogel-based studies remain preclinical, necessitating rigorous clinical evaluations. Patient-specific factors, potential complications, and the current nascent stage of research should inform their clinical application. In essence, the incorporation of hydrogels into ocular therapeutics represents a seminal convergence of material science and medicine, heralding advancements in patient-centric care within ophthalmology.

Citing Articles

Advancements in Hydrogels for Corneal Healing and Tissue Engineering.

Wu K, Qian S, Faucher A, Tran S Gels. 2024; 10(10).

PMID: 39451315 PMC: 11507397. DOI: 10.3390/gels10100662.

References
1.
Cai M, Chen X, Fu L, Du W, Yang X, Mou X . Design and Development of Hybrid Hydrogels for Biomedical Applications: Recent Trends in Anticancer Drug Delivery and Tissue Engineering. Front Bioeng Biotechnol. 2021; 9:630943. PMC: 7925894. DOI: 10.3389/fbioe.2021.630943. View

2.
Hu C, Chiu Y, Chaw J, Chen C, Liu H . Thermo-responsive hydrogel as an anti-VEGF drug delivery system to inhibit retinal angiogenesis in Rex rabbits. Technol Health Care. 2019; 27(S1):153-163. PMC: 6597966. DOI: 10.3233/THC-199015. View

3.
Murakami T, Hoshi S, Okamoto F, Sakai T, Katashima T, Naito M . Analysis of the sustained release ability of bevacizumab-loaded tetra-PEG gel. Exp Eye Res. 2022; 223:109206. DOI: 10.1016/j.exer.2022.109206. View

4.
Liu S, Tang J, Ji F, Lin W, Chen S . Recent Advances in Zwitterionic Hydrogels: Preparation, Property, and Biomedical Application. Gels. 2022; 8(1). PMC: 8775195. DOI: 10.3390/gels8010046. View

5.
Krohn J, Bertelsen T . Light microscopy of uveoscleral drainage routes after gelatine injections into the suprachoroidal space. Acta Ophthalmol Scand. 1998; 76(5):521-7. DOI: 10.1034/j.1600-0420.1998.760502.x. View